Farther Finance Advisors’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.4K | Sell |
71
-385
| -84% | -$111K | ﹤0.01% | 2655 |
|
|
2025
Q1 | $140K | Buy |
456
+77
| +20% | +$23.6K | ﹤0.01% | 1381 |
|
|
2024
Q4 | $134K | Buy |
379
+23
| +6% | +$8.12K | ﹤0.01% | 1184 |
|
|
2024
Q3 | $128K | Buy |
356
+310
| +674% | +$111K | ﹤0.01% | 1197 |
|
|
2024
Q2 | $14.7K | Buy |
46
+12
| +35% | +$3.83K | ﹤0.01% | 1904 |
|
|
2024
Q1 | $7.76K | Sell |
34
-28
| -45% | -$6.39K | ﹤0.01% | 1861 |
|
|
2023
Q4 | $13.6K | Buy |
62
+21
| +51% | +$4.62K | ﹤0.01% | 1470 |
|
|
2023
Q3 | $9.26K | Sell |
41
-1
| -2% | -$226 | ﹤0.01% | 1312 |
|
|
2023
Q2 | $9.27K | Buy |
42
+7
| +20% | +$1.55K | ﹤0.01% | 1223 |
|
|
2023
Q1 | $7.84K | Hold |
35
| – | – | ﹤0.01% | 1201 |
|
|
2022
Q4 | $9.73K | Buy |
+35
| New | +$9.73K | ﹤0.01% | 949 |
|